Navigation Links
Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO

e events were reported. Grade 4 lymphopenia, neutropenia and thrombocytopenia were observed in 1, 2 and 2 patients, respectively. Grade 1-3 anemia, nausea/vomiting and hypocalcemia were observed in 18, 1, and 3 patients, respectively.

"Myelosuppression, particularly neutropenia, is a substantial clinical problem in patients with relapsed NHL," said Dr. Scott E. Smith, MD, PhD, Assistant Professor of Medicine at Loyola, who was the principal investigator of this trial. "Based on these favorable results, we have organized a followup trial of GaRD used in combination with another standard regimen that we expect to initiate in a Chicago-based clinical collaboration."

About Ganite

Ganite was originally developed by the U.S. National Cancer Institute as a cancer chemotherapy drug. A separate series of studies showed that the drug markedly reduced the loss of calcium from bone - an observation that suggested the drug may be useful in hypercalcemia, as well as other conditions associated with loss of bone mass. Ganite is approved in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration.

Important Safety Information about Ganite(R) (gallium nitrate injection)

Ganite is contraindicated in patients with severe renal impairment (serum creatinine > 2.5 mg/dL). While Ganite was generally well tolerated by patients who received the drug in clinical trials, concurrent use of Ganite with other potentially nephrotoxic drugs like aminoglycosides and amphotericin B may increase the risk for developing severe renal insufficiency in patients with cancer-relapsed hypercalcemia. If use of a potentially nephrotoxic drug is indicated during Ganite therapy, Ganite should be discontinued and hydration for several days is recommended. Please see accompanying full Prescribing Information in the Package Insert or on the Ganite website at http://www.ganite
'"/>





Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com ... available in its catalogue: Global Heart ... http://www.reportlinker.com/p02316644/Global-Heart-Valve-Repair-and-Replacement-Market-2014-2018.html About Heart ... in the human heart which control the flow ... affected with heart valve diseases such as valvular ...
(Date:8/27/2014)... 2014 Reportlinker.com announces that a new market ... Baby Food Eastern Europe 2014 ... 2014" is a new report by ERC that analyzes ... Eastern Europe , key segments, features & developments, ... examines trends which are currently affecting the industry. Furthermore, ...
(Date:8/27/2014)... North American lighting leader OSRAM SYLVANIA ... the new OSRAM ITOS ® PHASER ® 3000, ... microscopy, endoscopy and surgical head lamps that delivers the same ... lamp life. "We,re honored to be recognized by ... new technologies of the past year," said Andreas Osten ...
Breaking Medicine Technology:Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4Baby Food Eastern Europe 2014 2Baby Food Eastern Europe 2014 3Baby Food Eastern Europe 2014 4Baby Food Eastern Europe 2014 5Baby Food Eastern Europe 2014 6Baby Food Eastern Europe 2014 7Baby Food Eastern Europe 2014 8OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3
(Date:8/27/2014)... Spring, Md. (PRWEB) August 27, 2014 ... (CHEST) recently released guidelines for the management and ... Pharmacological Therapy for Pulmonary Arterial Hypertension in Adults: ... are free to view for clinicians, and provide ... PAH. , The Pulmonary Hypertension Association ...
(Date:8/27/2014)... Seventy-three members of the founding class of the ... their careers as healthcare professionals at a traditional White ... four-year PharmD program traditionally receive white coats?a symbol of ... profession as colleagues dedicated to patient care. At the ... in Claremont, Calif., KGI President Sheldon Schuster welcomed the ...
(Date:8/27/2014)... Aug. 27, 2014 (HealthDay News) -- Young adults who ... networks in their brain, researchers are reporting. The ... to new ways to predict, prevent and treat the ... researchers. The researchers conducted brain scans on 30 ... their teen years, and a control group of 23 ...
(Date:8/27/2014)... Texas (PRWEB) August 28, 2014 BRIC ... Outlook to 2020?, provides key market data on the ... of US dollars, volume (in units) and average prices ... Tip Video Laparoscopes and Flexible Tip Video Laparoscopes), Robotic ... are a number of advantages to the patient with ...
(Date:8/27/2014)... 27, 2014 Sound Telecom, a leading ... and cloud-based business communication systems, has unveiled an article ... HIPAA-compliant Secure Text Messaging .” The piece examines the ... to do to remain compliant with HIPAA and HITECH ... article and C.O.O. at Sound Telecom, opens with evidence ...
Breaking Medicine News(10 mins):Health News:Pulmonary Hypertension Association Endorses CHEST Guidelines for Treatment of Pulmonary Arterial Hypertension in Adults 2Health News:Founding Class of the KGI School of Pharmacy Formally Welcomed into the Profession at a Traditional White Coat Ceremony 2Health News:Study: Young Adults Who Had Depression Have 'Hyper-Connected' Brain Networks 2Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 2Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 3Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 4Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 2Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 3
... Using the same technology found in clothing tags used in ... North Carolina at Chapel Hill shows that surgical sponges with ... to manual counting and X-ray detection in preventing sponges from ... UNC surgeons will report the preliminary results of the study ...
... new form of immunotherapy to children with neuroblastoma, a ... were alive and free of disease progression after two ... San Diego School of Medicine and fellow institutions. The ... standard therapy to 66 percent for children receiving immunotherapy ...
... Amanda Gardner HealthDay Reporter , WEDNESDAY, Sept. ... a progestin hormone may be an effective treatment for ... By delaying a total hysterectomy, which is the ... to remain fertile and possibly to have families, according ...
... program headed by Washington University School of Medicine ... for heart and lung diseases that use,nanotechnology. ... Blood Institute, will fund five years of research ... University, University of Texas Southwestern Medical Center, and ...
... MD, an assistant professor in the department of medicine ... the Department of Defense Lung Cancer Promising Clinician Research ... factors in the progression of lung cancer. It is ... the molecular progression of lung tumors and help identify ...
... HealthDay Reporter , TUESDAY, Sept. 28 (HealthDay News) ... specific proteins may indicate the presence of prostate cancer more ... The test, which has thus far only been ... returned fewer false-positive results than the prostate specific antigen (PSA) ...
Cached Medicine News:Health News:No sponge left behind 2Health News:Addition of immunotherapy boosts pediatric cancer survival in children with neuroblastoma 2Health News: IUD Proposed to Treat Uterine Cancer 2Health News: IUD Proposed to Treat Uterine Cancer 3Health News:WUSTL awarded $18 million to treat heart, lungs with nanotechnology 2Health News:WUSTL awarded $18 million to treat heart, lungs with nanotechnology 3Health News:BU School of Medicine researcher receives Department of Defense award 2Health News:Experimental Test May Spot Prostate Cancer Earlier, More Accurately 2Health News:Experimental Test May Spot Prostate Cancer Earlier, More Accurately 3
... super series slit ... Examination through small ... fundus diagnostic capability, ... potential field of ...
... Volk's super ... biomicroscopy lenses. General ... Provide unprecedented fundus ... addressing maximum potential ...
Volk indirect lenses. General diagnosis / small pupil examinations....
Volk indirect lenses. General diagnosis & treatment....
Medicine Products: